Àá½Ã¸¸ ±â´Ù·Á ÁÖ¼¼¿ä. ·ÎµùÁßÀÔ´Ï´Ù.

Àü¸³¼±ºñ´ëÁõ ȯÀÚ¿¡¼­ ºÎºÐ ȤÀº ±¹¼Ò¸¶ÃëÇÏ¿¡¼­ ·¹ÀÌÀú¸¦ ÀÌ¿ëÇÑ Àü¸³¼±ÀýÁ¦¼úÀÇ ÀÓ»ó°æÇè 77·Ê Clinical Experience of Laser Prostatectomy under Regional or Local Anesthesia in 77 Patients with Benign Prostatic Hyperplasia

´ëÇѺñ´¢±â°úÇÐȸÁö 1998³â 39±Ç 2È£ p.162 ~ 166
¹Ú¸í½Â, ¹ÚÁ¾°ü, ÀÓä»ó,
¼Ò¼Ó »ó¼¼Á¤º¸
¹Ú¸í½Â (  ) 
ÀüºÏ´ëÇб³ ÀÇ°ú´ëÇÐ ºñ´¢±â°úÇб³½Ç

¹ÚÁ¾°ü (  ) 
ÀüºÏ´ëÇб³ ÀÇ°ú´ëÇÐ ºñ´¢±â°úÇб³½Ç
ÀÓä»ó (  ) 
ÀüºÏ´ëÇб³ ÀÇ°ú´ëÇÐ ºñ´¢±â°úÇб³½Ç

Abstract

°á·Ð
º» ±³½Ç¿¡¼­ Ãʱ⠰æÇèÇÑ lased prostatectomy 77·Ê¸¦ ´ë»óÀ¸·Î ÀÓ»óÀû °á°ú¸¦ ºñ±³ ºÐ¼®
½Ã 1, 3, 6°³¿ù°ú 1³â ÃßÀû°Ë»ç¿¡¼­ AUA symptom score´Â °¨¼ÒÇÏ¿´À¸¸ç, ÃÖ´ë¿ä¼ÓÀº ¿ä¿ª
µ¿ÇÐ °Ë»ç»ó È£ÀüµÈ ÁÁÀº °á°ú¸¦ º¸¿´´Ù.
¼ö¼ú ÈÄ ÀÌȯ·ü, ÇÕº´Áõ°ú ¼ö¼ú ÈÄ Áõ»ó µîÀÇ ÇöÀúÇÑ °¨¼Ò°á°ú¸¦ º¸¿´°í, ƯÈ÷ ¼ö¼ú¿¡ ´ëÇÑ
½ºÆ®·¹½º°¡ Àû¾î ȯÀÚ³ª º¸È£Àڵ鿡°Ô Àü¸³¼±ºñ´ëÁõÀÇ ÀÏÂ÷Àû ¼ö¼ú¿ä¹ýÀ¸·Î ¼±È£µµ°¡ ¸Å¿ì
³ô¾Ò´Ù.
VAS¸¦ ÀÌ¿ëÇÑ ¼ö¼ú Áß ÅëÁõÁ¤µµ Æò°¡ÀÇ Æò±ÕÄ¡´Â 30.6mm·Î ÀÓ»óÀûÀ¸·Î ÀÇÀÇ ÀÖ´Â ¼öÄ¡
¸¦ º¸¿© ,µ¿¹ÝµÈ ³»°úÀû ÁúȯÀ¸·Î Àü½Å¸¶Ã볪 ô¼ö¸¶Ãë°¡ ¾î·Á¿ü´ø ȯÀÚ¿¡¼­µµ ±¹¼Ò¸¶Ãë ÇÏ
¿¡¼­ laser prostatectomy°¡ ¾ÈÀüÇÏ°Ô ½ÃÇàµÉ ¼ö ÀÖ¾ú´Ù.
Àü¸³¼±ºñ´ëÁõÀÇ ÃÖ±Ù Ä¡·á °æÇâÀÌ º¸´Ù °£ÆíÇÏ°í ºñħÇØÀûÀ̸鼭µµ ¸¸Á·ÇÒ¸¸ÇÑ Ä¡·á¹æ¹ýÀ»
¿øÇÏ°í ÀÖ°í, laser prostatectomy°¡ ÀÌ¿¡ ºÎÀÀÇÏ´Â ÁÁÀº Ä¡·á°á°ú¸¦ º¸¿©, ÀÓ»óÀû ÀÀ¿ë¿¡¼­
°æ¿äµµÀû Àü¸³¼±ÀýÁ¦¼úÀ» ´ëÄ¡ÇÒ¸¸ÇÑ ºñħÇØÀûÀÌ°í È¿°úÀûÀÎ Ä¡·á¹æ¹ýÀ¸·Î »ç·áµÇ¸ç, ¾ÕÀ¸
·Î ´õ ¸¹Àº ȯÀÚ¿¡¼­ Àå±â°£ÀÇ ÃßÀû°üÂûÀÌ ÀÌ·ç¾îÁø ÈÄ¿¡ laser prostatectomyÀÇ Á¤È®ÇÑ Æò
°¡°¡ ÀÌ·ç¾îÁú ¼ö ÀÖÀ¸¸®¶ó°í »ý°¢ÇÑ´Ù.
#ÃÊ·Ï#
Purpose: This prospective study was designed to evaluate the efficacy and safety of
Nd: YAG laser for the treatment of benign prostatic hyperplasia(BPH).
Materials and Methods: From January 1994 to March 1995, 77 patients with BPH were
underwent laser prostatectomy. Of the 77 patients 17 were performed under local
anesthesia. Preoperative and postoperative(at 1, 3 and 6months after operation) evaluation
consisted of uroflowmetry, American Urological Association(AUA) symptom score and
posboid residual urine. There were no limits of the prostatic size for operation and 2
cases had 100gm of prostatic weight. Multiple dragging technique(from the bladder neck
to the verumontanum) with 90¡Æfiber at 80 to 90watts power were used in near contact
or contact.
Results: 69 patients of total 77 patients have completed 6months follow-up evaluation.
Mean prostatic size was 39.7gm. Preoperative mean urine flow rate was 3.0ml/sec and
postoperative urine flow rate at one, three and six months was 10.7, 13.8 and
13.6m1/sec, respectively.
Preoperative AUA score was 26.6 and postoperative AUA score at one, three and six
month was 9.6, 7.6, respectively. Preoperative residual urine was 251.4ml and
postoperative residual urine at one, three and six months was 57.0, 15.3 and 19.4ml,
respectively. In 17 cases laser prostatectomy was done under local anesthesia due to
poor medical condition. The results of laser prostatectomy under local anesthesia was
not different from the cases with regional anesthesia. And the degree of subjective Pain
of the Patients in local anesthesia was tolerable.
The total energy used was about 129,000 Joules and the mean operative time was 103
minutes. Foley catheter was removed on postoperative 5th day. A total of 7 patients
failed in initial voiding trials and required catheterization longer than 2weeks
postoperatively. In 3 cases of seven patients who complained discomfort on voiding after
3months, necrotic tissue was present on cystoscopy. There were no severe
complications.
Conclusion: It is concluded that the technique of transurethral laser-induced
prostatectomy is effective and less invasive technique alterative than traditional
transurethral resection of the prostate.

Å°¿öµå

Benign prostatic hyperplasia; Laser prostatectomy;

¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸

   

µîÀçÀú³Î Á¤º¸

KCI
KoreaMed
KAMS